Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19.
In: BMC Complementary Medicine & Therapies, Jg. 22 (2022-09-30), Heft 1, S. 1-9
Online
academicJournal
Zugriff:
Background: Complementary and Integrative Medicine (CIM) is often taken up by individuals seeking relief from different diseases. This study investigates the prevalence and associated factors of CIM use in patients with COVID-19. Methods: In this telephone-based, cross-sectional study, data on CIM usage were collected from COVID-19 patients from February till June 2020 in Fars province, Iran using a researcher-made checklist. Additionally, we asked about the patients' attitudes toward these treatments. Results: Out of 453 patients diagnosed with COVID-19, 400 (88.30%) responded to our calls and agreed to participate in the study. Among them, 276 patients reported using CIM to treat COVID-19 [prevalence: 69% (95% CI: 64.2 to 73.5)]. The most frequently used herbal medicine among COVID-19 patients was ginger (n = 273, 98.9%), thyme (n = 263, 95.3%), and black cumin (n = 205, 74.3%). Most of these patients were recommended to use herbal medicine by their families and friends (n = 96, 34.8%). Univariable logistic regression revealed that age under 50 years old, residency in urban areas (including the capital of the province and small cities), employment, academic education, and being an outpatient were statistically significant factors resulting in CIM usage. Multivariable logistic regression revealed that CIM use among outpatients was 3.65 times more than among inpatients. In addition, patients under 50 years old used CIM 85% more than older patients. Ultimately, only 9 (3.3%) patients consulted with their doctors regarding these medications. No side effects due to CIM use were reported. Conclusion: Many patients with COVID-19 used CIM, but few consulted with their physicians in this regard. Therefore, physicians should ask their patients about CIM usage, and patients should also report their use of CIM therapies during their medical visits. Furthermore, age and hospitalization status affected CIM use among patients with COVID-19. [ABSTRACT FROM AUTHOR]
Copyright of BMC Complementary Medicine & Therapies is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Prevalence and associated factors of complementary and integrative medicine use in patients afflicted with COVID-19.
|
---|---|
Autor/in / Beteiligte Person: | Parvizi, Mohammad Mahdi ; Forouhari, Sedigheh ; Shahriarirad, Reza ; Shahriarirad, Sepehr ; Bradley, Ryan D ; Roosta, Leila |
Link: | |
Zeitschrift: | BMC Complementary Medicine & Therapies, Jg. 22 (2022-09-30), Heft 1, S. 1-9 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 2662-7671 (print) |
DOI: | 10.1186/s12906-022-03722-x |
Schlagwort: |
|
Sonstiges: |
|